This atherogenic dyslipidemia consists of an excess of atherogenic apolipoprotein B (ApoB)-containing lipoproteins, which is reflected by higher circulating ApoB, non-high-density lipoprotein cholesterol (non-HDL-C), and low-density lipoprotein particle number (LDL-PN) [1, 3, 4]. Here, APOB is linked to metabolic syndrome.